Atlas Trials

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

Clinical trial NCT00651482 · TERMINATED

Trial details

NCT number
NCT00651482
Sponsor
Sandy Srinivas
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney NeoplasmsKidney (Renal Cell) Cancer
Start date
2008-08-01
Primary completion
2012-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.